Plain-English translation of NCT03539133 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to understand why some patients recover better than others after a serious type of heart attack called STEMI. By collecting detailed medical information from 1,000 patients over time, they hope to discover the key factors that determine who is at higher risk and who does better — information that could eventually lead to better treatments for everyone.
Despite improvements in emergency care and treatment, serious heart attacks still cause significant illness and death. This study exists to identify the hidden patterns and 'master switches' in how heart attacks damage the body, so doctors can one day predict outcomes and personalize treatment for each patient.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to collect your medical information — including test results, hospital records, and health details — as part of this long-term registry study. There are no experimental drugs or procedures; instead, doctors will track your health and outcomes over time to identify patterns that help explain why heart attacks affect people differently.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Germany
Enrollment target
~1,000 participants
Started
October 2017
Primary completion
June 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Christian Jung, MD, PhD
Division of Cardiology, Pulmonary Disease and Vascular Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.